Advertisement

Experimental Anticancer Drug Reverses Schizophrenia

by Sheela Philomena on  April 1, 2014 at 5:53 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

In mice, experimental cancer drug reverses behaviors associated with schizophrenia, reveals study.

According to Johns Hopkins researchers, the drug was able to restore some lost brain cell function in adolescent mice with a rodent version of the devastating mental illness.
 Experimental Anticancer Drug Reverses Schizophrenia
Experimental Anticancer Drug Reverses Schizophrenia

The drug, which is of a class of compounds known as PAK inhibitors, was able to partially restore disabled neurons so they could connect to other nerve cells.

The scientists found that compound, called FRAX486, appears to halt an out-of-control biological "pruning" process in the schizophrenic brain during which important neural connections are unnecessarily destroyed.

The study was published in the Proceedings of the National Academy of Sciences.

Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Schizophrenia Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Advertisement

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive